Myasthenic crisis (MC) is a life‐threatening manifestation of myasthenia gravis (MG) defined
by respiratory insufficiency that requires the use of invasive or non‐invasive ventilation. This …

Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

There are substantial disease and health-related quality-of-life (HRQoL) burdens for many
patients with myasthenia gravis (MG), especially for those whose disease symptoms are not …

Introduction Myasthenia gravis (MG) is a neuromuscular disease causing extreme muscular
fatigue, triggering problems with vision, swallowing, speech, mobility, dexterity, and …

Myasthenia gravis (MG) is a chronic autoimmune disease for which multiple
immunomodulatory therapies are available. Nevertheless, MG has a significant impact on …

Introduction Myasthenia gravis (MG) is a rare neuromuscular disorder marked by a variable
combination of weakness of eye, bulbar, respiratory, axial, and limb muscles. This study …

Objective Myasthenia gravis (MG) people experience adverse psychiatric outcomes, which
may impact on their life and disturb their daily activity. Depression and anxiety are identified …

Psychiatric comorbidities are relevant in patients with Myasthenia gravis (MG). Also, MG
patients experience a reduced health-related quality of life (HRQoL). We aimed to quantify …

Objective Better understanding the impact of social determinants of health (SDOH) barriers
from the patient perspective is crucial to improve holistic patient support in generalized …

Introduction Even treated, myasthenia gravis (MG) continues to represent a significant
burden and might continuously affect patients' quality of life (QoL). The aim of our …